The White House
White House debuts new actions to protect the LGBTQ community
The administration is coordinating efforts across different federal agencies
White House Domestic Policy Advisor Neera Tanden, during a call with reporters on Wednesday, announced a slate of new actions the administration will undertake to better protect the LGBTQ community.
These will focus on three major areas, she said: safety and security, issues for LGBTQ youth like mental health and housing insecurity, and combatting book bans.
President Joe Biden has “already developed a historic record of supporting the LGBTQ community,” Tanden said, noting that he and First Lady Dr. Jill Biden are also prepared to “host the largest Pride celebration in White House history” on Thursday evening.
At the same time, she said, LGBTQ Americans are now experiencing “a whole range of attacks” from “hateful, un-American legislation” to “a disturbing surge in violent threats.”
Administered by the U.S. Department of Homeland Security in partnership with the U.S. Department of Justice and U.S. Department of Health and Human Services, the administration’s “community safety partnership” will “work hand in hand with LGBTQ community organizations” to provide safety training and resources, Tanden said.
For example, she said, “and it’s so unfortunate to have to say this,” but the partnership will help LGBTQ community centers “prepare for the worst” – including “bomb threats, active shooters, and cybersecurity threats – while also protecting “healthcare providers who serve the community by working with doctors and medical associations.”
Actions for LGBTQ kids that Tanden previewed on Wednesday include HHS’s development of a behavioral health care advisory for transgender and gender diverse youth, to help ensure young people are given the best evidence-based care.
On Thursday, she said, the U.S. Department of Housing and Urban Development will launch federal initiatives to combat LGBTQ youth homelessness and new regulations to “protect LGBTQ kids in foster care.”
Finally, Tanden said, the U.S. Department of Education’s Office for Civil Rights “will appoint a new coordinator” to combat book bans, which disproportionately target, for exclusion, materials with LGBTQ characters or themes, or communities of color.
DoE’s coordinator will “offer trainings and resources to schools to help them understand that students have a right to learn free from discrimination, and that book bands may violate federal civil rights laws if they create a hostile environment for students,” Tanden said.
A senior administration official, responding to a question from the Washington Blade following Tanden’s remarks, elaborated on the scope of the community safety partnership.
Community organizations, they said, will include “health clinics, community centers, and organizations that are planning Pride celebrations, but it also includes small businesses like restaurants and bars that have been targeted because they’re run by LGBTQI+ Americans or because they host events that support that community.”
“We’ll be encouraging and reaching out directly to organizations that have been impacted by these violent threats to help make sure that they have the training and the resources they need to stay safe,” the official said.
They added that DHS and DoJ, in anticipation of the possibility that threats will increase in June, “have both been working proactively over many months leading up to Pride to communicate with state and local law enforcement about the threats that the community may face and to help local pride organizers get access to any federal safety resources they may need to help keep the community safe.”
Asked to explain how HHS’s healthcare focused initiatives will be reconciled with restrictions targeting medical interventions for trans youth in conservative states, the official noted ongoing efforts to fight back – including by federal rulemaking and litigated challenges of policies that violate Americans’ rights.
When it comes to the actions previewed by Tanden, the official said, “Almost half of LGBTQI+ youth say they seriously considered committing suicide in the past year, and that attacks on their rights have made their mental health worse. That’s a serious crisis that we want to take on and this advisory will help.”
Additionally, they said, “HHS is announcing that they’re going to release new guidance to states to help them use federal funds to offer dedicated mental health services to the LGBTQI+ community,” while “the Substance Abuse and Mental Health Services Administration, or SAMSA, is releasing $1.7 million in new federal funding for programs that support the health and mental health of LGBTQI+ youth by investing in programs that are focused on family affirmation.”
Responding to other questions about anti-LGBTQ legislation and the rising transphobic and anti-LGBTQ sentiment in America, the official offered some insight into the Biden-Harris administration’s positions on these matters more broadly.
“Part of our role here is to lift up the stories of transgender kids and their families to help the American people understand what is happening to families who, as the President says aren’t hurting anyone but are being hurt by these laws,” said the official.
“These aren’t just attacks on the rights of LGBTQI+{ Americans, they are part and parcel of a coordinated attack on our democracy,” they said. “We’re not just talking about laws that target transgender kids. These are really laws that get at the heart of our basic freedoms and values: the right to free expression, the right to make decisions about your own body, the right to parent and raise your children.”
The official added, “Opponents of LGBTQI+ Americans are leading a pretty significant campaign of disinformation,” which have included “the same types of hateful lies and stereotypes that have been used against our community really for decades and for generations.”
“President Biden’s new executive actions today, protecting LGBTQI+ communities from attacks on their rights and safety, are an important step in the right direction, and to me, they’re personal,” said AmeriCorps CEO Michael D. Smith in a statement Thursday.
“When I was appointed by President Biden to lead AmeriCorps, defending and advancing the rights of LGBTQI+ communities was one of my top priorities, because we work and serve in communities like the one I grew up in,” Smith said.
“As a Black gay man, I’m truly honored – especially on days like today – to serve with President Biden and Vice President Harris, who have continuously fought for underserved communities across our great country.”
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
The White House
Empty seats, canceled shows plague Kennedy Center ahead of Trump renaming
It would take an act of Congress to officially rename the historic music venue, despite the Trump-appointed board’s decision.
The board of the Kennedy Center in Washington, D.C., voted to rename it the Trump-Kennedy Center, according to the White House Press Office.
White House Press Secretary Karoline Leavitt announced the decision in a post on X Thursday, thanking the president for his work on the cultural center “not only from the standpoint of its reconstruction, but also financially, and its reputation.”
Speaking to reporters later that day at the White House, Trump said he was “surprised” and “honored” by the board’s vote.
“This was brought up by one of the very distinguished board members, and they voted on it, and there’s a lot of board members, and they voted unanimously. So I was very honored,” he said.
Earlier this year, GOP Rep. Mike Simpson of Idaho introduced an amendment that would have renamed the building after first lady Melania Trump, later saying she had not been aware of his efforts prior to the amendment’s public introduction.
Despite the board’s vote (made up of Trump-appointed loyalists), the original laws guiding the creation of the Kennedy Center during the Eisenhower, Kennedy, and Johnson administrations explicitly prohibit renaming the building. Any change to its name would require an act of Congress.
Trump has exerted increasing control over the center in recent months. In February, he abruptly fired members of the Kennedy Center’s board and installed himself as chair, writing in a Truth Social post at the time, “At my direction, we are going to make the Kennedy Center in Washington D.C., GREAT AGAIN.”
In that post, Trump specifically cited his disapproval of the center’s decision to host drag shows.
He later secured more than $250 million from the Republican-controlled Congress for renovations to the building.
Since Trump’s takeover, sales of subscription packages are said to have declined, and several touring productions — including “Hamilton” — have canceled planned runs at the venue. Rows of empty seats have also been visible in the Concert Hall during performances by the National Symphony Orchestra.
“The Kennedy Center Board has no authority to actually rename the Kennedy Center in the absence of legislative action,” House Minority Leader Hakeem Jeffries told reporters.
For decades, the Kennedy Center has hosted performances by LGBTQ artists and companies, including openly queer musicians, choreographers, and playwrights whose work helped push LGBTQ stories into the cultural mainstream. Those artists include the Gay Men’s Chorus of Washington, Harvey Fierstein, and Tennessee Williams.
In more recent years, the center has increasingly served as a space for LGBTQ visibility and acceptance, particularly through Pride-adjacent programming and partnerships.
That legacy was on display at this year’s opening production of Les Misérables, when four drag performers — Tara Hoot, Vagenesis, Mari Con Carne, and King Ricky Rosé — attended in representation of Qommittee, a volunteer network uniting drag artists to support and defend one another amid growing conservative attacks.
“We walked in together so we would have an opportunity to get a response,” said Tara Hoot, who has performed at the Kennedy Center in full drag before. “It was all applause, cheers, and whistles, and remarkably it was half empty. I think that was season ticket holders kind of making their message in a different way.”
The creation of the Kennedy Center is outlined in U.S. Code, which formally designates the institution as the John F. Kennedy Center for the Performing Arts.
As a result, it appears unlikely that Congress will come together to pass legislation allowing the historic venue to be renamed.
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
